Goldman Sachs analyst Jamie Perse maintained a Buy score on Option Care Health (OPCH – Research Report), with a price target of $41. 00.
In a report published on July 25, Barrington also maintained a Buy level on the stock with a price target of $38. 00.
Option Care Health (OPCH) Company Description:
Option Care Health, Inc. provides infusion at home and elsewhere. The company was founded in 1996 and is headquartered in Bannockburn, Illinois.
Learn more about OPCH: